Afghanistan

in page functions
[French]
Afghanistan
Total population (2017) 34,169,138
Birth cohort (2017) 1,083,160
Surviving Infants (surviving to 1 year per year, 2017) 1,013,596
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 66/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 91/1000
World Bank Index, IDA (2015) 2.69
Gross Nation Income (per capita US$, 2015) 610
Co-financing group (2017) Initial self-financing
No. of districts/territories (2015) 329

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Afghanistan

Type of support

Approvals

2001-2021 (US$)
(29 Jun 2017)

Commitments

2001-2021 (US$)
(29 Jun 2017)

Disbursements

2000-2017 (US$)
(29 Jun 2017)

% Disbursed

(29 Jun 2017)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019
Total $270,520,025 $336,714,599 $262,507,056
Civil Society Organisation support (CSO) $3,576,400 $3,576,400 $3,892,300 109%
Health system strengthening (HSS 1) $34,100,000 $34,100,000 $34,100,000 100%
Health system strengthening (HSS 2) $17,188,768 $18,001,661 $16,469,963 96%
Health system strengthening (HSS 3) $21,133,677 $39,898,858 $10,822,008 51%
Immunisation services support (ISS) $14,025,300 $14,025,300 $14,025,300 100%
Injection Safety Devices (NVS) $617,500 $1,636,500 $763,916 124%
Injection safety support (INS) $1,676,500 $1,676,500 $1,676,500 100%
IPV (NVS) $2,815,155 $2,815,155 $2,263,355 80%
Measles SIA (NVS) $2,163,903 $2,163,903 $2,163,903 100%
Measles SIA - Operational costs (OPC) $3,574,000 $3,574,000 $3,574,000 100%
Penta (NVS) $72,148,715 $84,305,215 $69,009,645 96%
Pneumo (NVS) $84,677,974 $118,118,974 $90,924,712 107%
Product Switch Grant (PSG) $406,500 $406,500 $405,821 100%
Tetra DTP-HepB (NVS) $9,903,633 $9,903,633 $9,903,633 100%
Vaccine Introduction Grant (VIG) $2,512,000 $2,512,000 $2,512,000 100%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Afghanistan DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 81%
M:F sex ratio at birth (2017) 1.06
Household survey: DTP3 coverage for male (2010) 41.60%
Household survey: DTP3 coverage for female (2010) 38.90%
Household survey: Last DTP3 survey (2010) 40%
% districts achieving > 80% DTP3 coverage (2015) 63%
% districts achieving < 50% DTP3 coverage (2015) 10%
MCV WHO/UNICEF estimates (2016) 62%

Breakdown of support

Non-vaccine support Vaccine support
33% 67%
$87,477,892 $175,029,164

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Afghanistan

15 June 2017

DRC: a nurse vaccinates a child

Gavi to help protect millions more children against polio

Gavi Board agrees to extend support for inactivated polio vaccine (IPV) to 2020; new policy on fragile settings, emergencies and refugees also approved.

24 October 2016

World Polio Day a

Polio portraits: voices from the frontline of eradication

Today marks World Polio Day, when the global community celebrates the immense progress and considers the work ahead to ensure no child suffers from polio ever again.

02 November 2015

Afghanistan airport

Afghanistan ensures safe passage of life-saving vaccines

Afghan health ministry shows commitment to immunisation by opening critical storage facility at central airport.

close icon

modal window here